Mobile home BP monitoring with coaching after high blood pressure from pregnancy
Official title: Multilevel Mobile Health Program to Improve Hypertension Among Midlife Women After Hypertensive Disorder of Pregnancy
Run by University of Pittsburgh · NCT07599579 · Data updated 2026-11-12
This program tests whether a home blood pressure monitoring system plus virtual coaching can help midlife women, 10–20 years after a hypertensive pregnancy, manage high blood pressure better than usual care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 50 (estimated) |
| Sponsor | University of Pittsburgh Academic / other |
| Locations | 1 site (Pittsburgh, Pennsylvania) |
| Status | Recruiting |
| Started | July 22, 2026 |
| Main results expected | July 2027 |
| Study ends | October 2027 |
| Registry record updated | July 29, 2026 |
| Trial ID | NCT07599579 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 10–20 years postpartum with a history of HDP (gestational hypertension or preeclampsia) and current stage 2 hypertension (BP ≥ 140/90 mmHg).
✕Probably not a fit
Individuals without persistent hypertension or with established cardiovascular disease may not derive benefit from this specific intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This intervention study tests a home blood pressure monitoring program combined with virtual coaching versus standard care for women 10 to 20 years after hypertensive disorders of pregnancy who now have stage 2 hypertension. Participants will use a coaching app and home BP monitoring to guide treatment and lifestyle changes, with an unblinded assignment to either the intervention or control group. The goal is to determine whether this approach improves blood pressure control and engagement in care. The study is led by the University of Pittsburgh at UPMC Magee-Womens Hospital, with support from the McKamish Family Foundation. Recruitment is limited to women with a history of gestational hypertension or preeclampsia and current uncontrolled hypertension, excluding those with existing clinical cardiovascular disease or who do not fit the postpartum window.
Why it matters
Potential benefit: If successful, the approach could improve blood pressure control and reduce cardiovascular risk for women years after a hypertensive pregnancy.
How similar studies have gone: Previous work supports home BP monitoring and coaching for hypertension, but applying it specifically to long-term post-HDP women is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women who had a history of HDP (either gestational HTN or preeclampsia) diagnosed by ACOG guidelines at the time of delivery at Magee-Womens Hospital between 2008 and 2015, thus 10 to 20 years from their index pregnancy complicated by HDP. * Evidence of current stage 2 HTN (BP ≥ 140/90 mmHg with or without treatment with antihypertensive medication). Exclusion Criteria: * Known clinical CVD (prior myocardial infarction, stroke, heart failure, or peripheral arterial disease). * Males will also be excluded from this study as it focuses on pregnancy related conditions. * Children will be excluded as the study is only recruiting people who are 10-20 years postpartum.
Where it's running
-
UPMC Magee Womens Hospital
Pittsburgh, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Malamo Countouris, MD, MS — University of Pittsburgh
- Study coordinator: Amy Travis
- Email: travisam@upmc.edu
- Phone: 4126413295
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Guiding Optimal Blood Pressure in Peritoneal Dialysis
This pilot tests whether aiming for a lower systolic blood pressure target (<120 mmHg) is feasible and practical for adults with end-stage kidney disease on peritoneal dialysis, compared to a <140 mmHg target.
-
Predicting Adverse Pregnancy Outcomes in Uganda through Partnerships and Innovation
This study tests whether everyday health data, ultrasound, and blood samples from first-time pregnant women in Uganda can help predict problems like preeclampsia, fetal growth restriction, and preterm birth.
-
New virtual care pathway for older adults with chronic diseases
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
-
Internal jugular vein collapsibility to gauge volume status in preeclampsia vs. normal pregnancy
This study tests whether ultrasound of the internal jugular vein can show differences in fluid status between preeclamptic pregnant people and those with normal blood pressure during planned cesarean delivery.
-
Higher vs lower daily aspirin in high-risk pregnant people
This study tests whether taking 150 mg of aspirin daily is more effective than 75 mg daily in preventing preeclampsia among pregnant people at high risk.
-
Community health worker support to lower blood pressure after pregnancy with high blood pressure
Postpartum patients with high blood pressure after pregnancy will try a program where a trained community health worker helps them monitor blood pressure and manage care for 6 months to see if it lowers blood pressure compared with usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.